[en] IkappaBalpha is an inhibitory molecule that sequesters NF-kappaB dimers in the cytoplasm of unstimulated cells. Upon stimulation, NF-kappaB moves to the nucleus and induces the expression of a variety of genes including IkappaBalpha. This newly synthesized IkappaBalpha also translocates to the nucleus, removes activated NF-kappaB from its target genes, and brings it back to the cytoplasm to terminate the phase of NF-kappaB activation. We show here that IkappaBalpha enhances the transactivation potential of several homeodomain-containing proteins such as HOXB7 and Pit-1 through a NF-kappaB-independent association with histone deacetylase (HDAC) 1 and HDAC3 but not with HDAC2, -4, -5, and -6. IkappaBalpha bound both HDAC proteins through its ankyrin repeats, and this interaction was disrupted by p65. Immunofluorescence experiments demonstrated further that IkappaBalpha acts by partially redirecting HDAC3 to the cytoplasm. At the same time, an IkappaBalpha mutant, which lacked a functional nuclear localization sequence, interacted very efficiently with HDAC1 and -3 and intensively enhanced the transactivation potential of Pit-1. Our results support the hypothesis that the NF-kappaB inhibitor IkappaBalpha regulates the transcriptional activity of homeodomain-containing proteins positively through cytoplasmic sequestration of HDAC1 and HDAC3, a mechanism that would assign a new and unexpected role to IkappaBalpha.
Li, Q., and Verma, I. (2002) Nat. Immunol. 2, 725-734
Sachdev, S., Hoffmann, A., and Hannink, M. (1998) Mol. Cell. Biol. 18, 2524-2534
Johnson, C., Van Antwerp, D., and Hope, T. J. (1999) EMBO J. 18, 6682-6693
Huang, T. T., and Miyamoto, S. (2001) Mol. Cell. Biol. 21, 4737-4747
Ghosh, S., and Karin, M. (2002) Cell 109, S81-S96
Whiteside, S. T., and Israël, A. (1997) Semin. Cancer Biol. 8, 75-82
Wulczyn, F. G., Naumann, M., and Scheidereit, C. (1992) Nature 358, 597-599
Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Bron, K., and Siebenlist, U. (1993) Cell 72, 729-739
Dechend, R., Hirano, F., Lehmann, K., Ansieau, S., Wulczyn, F. G., Scheidereit, C., and Leutz, A. (1999) Oncogene 18, 3316-3323
Chariot, A., Princen, F., Gielen, J., Merville, M.-P., Franzoso, G., Brown, K., Siebenlist, U., and Bours, V. (1999) J. Biol. Chem. 274, 5318-5325
Khochbin, S., Verdel, A., Lemercier, C., and Seigneurin-Berny, D. (2001) Curr. Opin. Genet. Dev. 11, 162-166
Brown, K., Park, S., Kanno, T., Franzoso, G., and Siebenlist, U. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2532-2536
Brown, K., Franzoso, G., Baldi, L., Carlson, L., Mills, L., Lin, Y.-C., Gerstberger, S., and Siebenlist, U. (1997) Mol. Cell. Biol. 17, 3021-3027
Bours, V., Burd, P. R., Brown, K., Villalobos, J., Park, S., Ryseck, R.-P., Bravo, R., Kelly, K., and Siebenlist, U. (1992) Mol. Cell. Biol. 12, 685-695
Zappavigna, V., Sartori, D., and Mavilio, F. (1994) Genes Dev. 8, 732-744
Peers, B., Voz, M. L., Monget, P., Mathy-Hartert, M., Berwaer, M., Belayew, A., and Martial, J. (1990) Mol. Cell. Biol. 10, 4690-4700
Caccavelli, L., Manfroid, I., Martial, J., and Muller, M. (1998) Mol. Endocrinol. 12, 1215-1227
Tagami, T., Madison, L. D., Nagaya, T., and Jameson, J. L. (1997) Mol. Cell. Biol. 17, 2642-2648
Chariot, A., Leonardi, A., Müller, J., Bonif, M., Brown, K., and Siebenlist, U. (2002) J. Biol. Chem. 277, 37029-37036
Hewitt, S. M., Hamada, S., Monarres, A., Kottical, L. V., Saunders, G. F., and McDonnell, T. J. (1997) Anticancer Res. 17, 3211-3216
Baek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., and Rosenfeld, M. G. (2002) Cell 110, 55-67
Saccani, S., Pantano, S., and Natoli, G. (2001) J. Exp. Med. 193, 1351-1359
Hoffmann, A., Levchenko, A., Scott, M. L., and Baltimore, D. (2002) Science 298, 1241-1245
Bushdid, P. B., Brantley, D. M., Yull, F. E., Blaeuer, G. L., Hooman, L. H., Niswander, L., and Kerr, L. D. (1998) Nature 392, 615-618